← Leaderboards
Philip Bauer
Endoprotech, Inc.
$1,180,489
Attributed
$3,402,614
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $974.5K · FY2012–19$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,402,614 · 4
By mechanism
R44$2,900,095 · 2
R43$502,519 · 2
Top collaborators
- Claudio Maldonado5 shared
- Leila Gobejishvili3 shared
- Xian-Liang Tang3 shared
Others in their field
Top investigators on “Vesicle”
- Marinella Temprosa · George Washington University$48,628,632
- Peter J Novick · Yale University$23,787,858
- Allan W Wolkoff · Yeshiva University$22,839,993
- Sandra L. Schmid · Scripps Research Institute$20,412,463
- Jose Rizo-Rey · Ut Southwestern Medical Center$19,806,380
- James E Rothman · Sloan-Kettering Institute For Cancer Res$18,867,780
Research focus
VesicleCellsInflammationCause Of DeathLipidsBaseAdverse EffectsProductionTreatment EfficacyDrug KineticsDoseSafetyNovel TherapeuticsInjuryAttenuatedLifeAreaAlcoholic Liver DiseasesChemokineAlcoholic Liver CirrhosisBlood - Brain Barrier AnatomyChronicBloodAlcoholic Hepatitis
Grant awards (6)
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$736,042
R44 · FY2019 · HL · contact PI
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$749,712
R44 · FY2018 · HL · contact PI
Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease$749,725
R44 · FY2016 · AA · contact PI
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$224,812
R43 · FY2016 · HL · contact PI
Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease$664,616
R44 · FY2015 · AA · contact PI
Device for Delivery of Rolipram to Liver for Treatment of Alcoholic Liver Disease$277,707
R43 · FY2012 · AA · contact PI